Use of β-Blockers in Pulmonary Hypertension

Abstract : Contrasting with the major attention that left heart failure has received, right heart failure remains understudied both at the preclinical and clinical levels. However, right ventricle failure is a major predictor of outcomes in patients with precapillary pulmonary hypertension because of pulmonary arterial hypertension, and in patients with postcapillary pulmonary hypertension because of left heart disease. In pulmonary hypertension, the status of the right ventricle is one of the most important predictors of both morbidity and mortality. Paradoxically, there are currently no approved therapies targeting the right ventricle in pulmonary hypertension. By analogy with the key role of β-blockers in the management of left heart failure, some authors have proposed to use these agents to support the right ventricle function in pulmonary hypertension. In this review, we summarize the current knowledge on the use of β-blockers in pulmonary hypertension.
Type de document :
Article dans une revue
Circulation. Heart failure, Lippincott Williams & Wilkins, 2017, 10 (4), pii: e00370. 〈10.1161/CIRCHEARTFAILURE.116.003703〉
Liste complète des métadonnées

Littérature citée [60 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01502296
Contributeur : Frédéric Perros <>
Soumis le : mercredi 5 avril 2017 - 12:08:45
Dernière modification le : mercredi 22 août 2018 - 15:20:07
Document(s) archivé(s) le : jeudi 6 juillet 2017 - 13:13:44

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Frédéric Perros, Frances De Man, Harm Bogaard, Fabrice Antigny, Gérald Simonneau, et al.. Use of β-Blockers in Pulmonary Hypertension. Circulation. Heart failure, Lippincott Williams & Wilkins, 2017, 10 (4), pii: e00370. 〈10.1161/CIRCHEARTFAILURE.116.003703〉. 〈inserm-01502296〉

Partager

Métriques

Consultations de la notice

130